Bladder Cancer Post-radical Cystectomy: Lifelong Follow-up Recommended

Share this content:
Radical cystectomy is part of routine treatment for patients with high-risk muscle-invasive or non-muscle-invasive bladder cancer.
Radical cystectomy is part of routine treatment for patients with high-risk muscle-invasive or non-muscle-invasive bladder cancer.

Patients with bladder cancer who undergo radical cystectomy are at a long-term risk of recurrence and should maintain lifelong follow-up, according to a study being published in Urology.1

Radical cystectomy is part of the standard treatment for patients with high-risk muscle-invasive or non-muscle-invasive bladder cancer, though up to half of patients have disease recurrence.

While recurrence within 3 years is well-studied, there are limited data about recurrence after 5-years (late recurrence). For this study, researchers attempted to determine whether particular characteristics and outcomes are associated with late recurrence of bladder cancer.

Researchers reviewed data from 1652 patients with bladder cancer who underwent radical cystectomy. The information was obtained from 3 referral centers; all patients underwent cystectomy between 1988 and 2012. 

Of all included patients, 548 patients had disease recurrence, 67 of whom had late recurrence. The characteristics associated with late recurrence included disease recurrent in the urothelium, patients being of younger age, and having non-organ defined disease.

After recurrent disease, 5-year overall survival was worse among patients with late recurrence (12%) vs patients with early recurrence (25%).

The authors concluded that “time to recurrence influenced the post-recurrence survival independent of the site of disease recurrence. Our findings support the need for life-long follow-up with a personalized schedule based on individual risk factors.” 

Reference

  1. Soria F, Moschini M, Wirth GJ, et al. Characterization of late recurrence after radical cystectomy in a large multicenter cohort of bladder cancer patients. Urology. In press.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters